Revolutionizing the treatment landscape in Crohn’s disease: How IL-23 and JAK inhibitors are changing the rhythm (AbbVie) (Complete Session)

Marc Ferrante  1     Krisztina Barbara Gecse  2     Laurent Peyrin-Biroulet  3    
1 University Hospitals Leuven, Leuven, Belgium
2 Amsterdam University Medical Center, Amsterdam, Netherlands
3 Inserm U1256, Nancy University Hospital, Vandoeuvre-les-Nancy, France

Session
Revolutionizing the treatment landscape in Crohn’s disease: How IL-23 and JAK inhibitors are changing the rhythm (AbbVie)

Conference
UEG Week 2023

Publisher

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing